Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan: one-year outcome of joint destruction (RECONFIRM-2J).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples